Literature DB >> 18394048

Effect of levetiracetam on cortical excitability: a transcranial magnetic stimulation study.

C Solinas1, Y C Lee, D C Reutens.   

Abstract

BACKGROUND AND
PURPOSE: We studied the effect of levetiracetam (LEV), an anticonvulsant with a novel mechanism of action, on cortical excitability, measured using transcranial magnetic stimulation (TMS). For this purpose, 38 healthy volunteers were assessed in two TMS sessions, before and after an oral dose of 3000 mg LEV.
METHODS: Resting motor threshold (RMT), intracortical facilitation (ICF) and intracortical inhibition (ICI), cortical silent period (CSP) threshold and duration and motor-evoked potential (MEP) amplitude were calculated.
RESULTS: After treatment with LEV, RMT was increased (mean +/- SD: 63 +/- 14% of the maximum stimulator output) compared with baseline (58 +/- 11%). CSP threshold was decreased after LEV (54 +/- 10%; baseline, 57 +/- 11%). CSP duration was increased after LEV (116 +/- 37 ms; baseline: 102 +/- 33 ms). LEV did not affect ICF or ICI or mean MEP amplitude significantly.
CONCLUSIONS: Our results indicate that LEV modulates some aspects of cortical excitability. Whereas the increase in the RMT most probably reflects the effect of LEV on ion channel activity, effects on the CSP might represent a modulation of GABA receptors at cortical and spinal level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394048     DOI: 10.1111/j.1468-1331.2008.02110.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Abnormal sensory-motor integration in a patient with anti-NMDA-receptor encephalitis.

Authors:  Yi-Hsuan Dou; Kuan-Lin Lai; Kwong-Kum Liao; Shih-Pin Chen
Journal:  J Neurol       Date:  2012-01-28       Impact factor: 4.849

2.  Effects of antiepileptic drugs on cortical excitability in humans: A TMS-EMG and TMS-EEG study.

Authors:  Ghazaleh Darmani; Til O Bergmann; Carl Zipser; David Baur; Florian Müller-Dahlhaus; Ulf Ziemann
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

3.  Suppression of myoclonus in corticobasal degeneration by levetiracetam.

Authors:  Jae Wook Cho; Jae Hyeok Lee
Journal:  J Mov Disord       Date:  2014-04-30

4.  Altered paired associative stimulation-induced plasticity in NMDAR encephalitis.

Authors:  Magdalena Sarah Volz; Carsten Finke; Lutz Harms; Betty Jurek; Friedemann Paul; Agnes Flöel; Harald Prüss
Journal:  Ann Clin Transl Neurol       Date:  2016-01-16       Impact factor: 4.511

5.  Lamotrigine and levetiracetam exert a similar modulation of TMS-evoked EEG potentials.

Authors:  Isabella Premoli; Andrea Biondi; Sara Carlesso; Davide Rivolta; Mark P Richardson
Journal:  Epilepsia       Date:  2016-11-03       Impact factor: 5.864

6.  The variability of motor evoked potential latencies in neurosurgical motor mapping by preoperative navigated transcranial magnetic stimulation.

Authors:  Nico Sollmann; Lucia Bulubas; Noriko Tanigawa; Claus Zimmer; Bernhard Meyer; Sandro M Krieg
Journal:  BMC Neurosci       Date:  2017-01-03       Impact factor: 3.288

7.  Myoclonus in older Cavalier King Charles Spaniels.

Authors:  Carina Rotter; Danielle Whittaker; Clare Rusbridge
Journal:  J Vet Intern Med       Date:  2022-03-23       Impact factor: 3.175

8.  The Effect of Lamotrigine and Levetiracetam on TMS-Evoked EEG Responses Depends on Stimulation Intensity.

Authors:  Isabella Premoli; Alyssa Costantini; Davide Rivolta; Andrea Biondi; Mark P Richardson
Journal:  Front Neurosci       Date:  2017-10-20       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.